Towards 3% R&D – Australia should choose a better target by Dr Matthew Young

Today in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Dr Matthew Young looks at the Australian government’s aim of close to doubling R&D spending to the equivalent of 3% of GDP, and concludes it might be better to set a better goal. Advocating for an increase in Australia’s national…

State government awards support to IDT for nation’s first ADC factory

Pharmaceutical manufacturer IDT Australia has announced that it has been awarded a Victorian government grant to assist in the establishment of an Australian-first facility for oncology drugs. In an ASX statement on Monday, IDT said it has established relationships with Antibody-Drug-Conjugate (ADC) biotech companies, including a master services  agreement with Japanese pharmaceutical company Nagase &…

No threat to farm land: just 1,200 square kilometres can fulfil Australia’s solar and wind energy needs

By Andrew Blakers, Australian National University As Australia’s rapid renewable energy rollout continues, so too does debate over land use. Nationals Leader David Littleproud, for example, claimed regional areas had reached “saturation point” and cannot cope with more wind and solar farms and transmission lines. So how much land is needed to fully decarbonise energy…

Towards 3% R&D – Australia’s climate opportunity by Dr Katherine Woodthorpe

Today in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Katherine Woodthorpe looks at the potential of innovation in low emission products for export. She argues investing in innovation and STEM skills has economic returns. In the fight against climate change, Australia and the world are at a crossroads. The…

Editorial series launch – Towards 3% R&D – turbocharging Australia’s Innovation Effort

Today @AuManufacturing launches its latest editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – with the bad, in fact the very bad news. After steadily rising since the 1980s, Australia’s innovation effort as measured by R&D spending has slumped dramatically in the past decade. Peter Roberts sets the scene. Innovation is the…

IDT and Sanofi to manufacture mRNA vaccines under development

Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…

Keynote speaker announced for Australia’s 50 Most Innovative Manufacturers awards event

@AuManufacturing is very happy to announce our keynote speaker for the Australia’s 50 Most Innovative Manufacturers awards breakfast this week. Our guest presenter on April 18 is Xavier Orr (pictured), CEO and co-founder of Advanced Navigation. Orr’s breakthrough in neural network research at university has turned into a manufacturing business supplying digital fibre optic gyroscopes…